US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Serina Therapeutics, Inc.

2.48

+1.2093.75%

Post-market: 2.500.0200+0.81%19:59 EDT

Volume:157.70M

Turnover:356.81M

Market Cap:26.75M

PE:-1.39

High:2.83

Open:2.10

Low:2.02

Close:1.28

52wk High:7.92

52wk Low:1.22

Shares:10.79M

Float Shares:5.19M

Volume Ratio:108.29

T/O Rate:3036.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7830

EPS(LYR):-1.5139

ROE:-485.36%

ROA:-137.85%

PB:-8.41

PE(LYR):-1.64

Loading ...

Overview Company News Filings

Top Midday Gainers

MT Newswires Live

Gold Tumbles Over 6%; Accenture Earnings Top Views

Serina Therapeutics names Greg Bailey co-chairman

Serina Therapeutics announces USD 15 million private placement of common stock and pre-funded warrants

Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors

Serina Therapeutics: Blinded Evaluation of Safety, Tolerability Data From Cohort 1 & Advancement to Cohort 2 Expected in 3Q 2026

THOMSON REUTERS

Serina Therapeutics doses first patient in SER-252 trial

Serina Therapeutics doses first patient in Phase 1b registrational trial of SER-252 for advanced Parkinson’s disease

Serina Therapeutics enrolls first patient in Phase 1b registrational trial of SER-252 for advanced Parkinson’s disease

Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Sale of Common Shares

Serina Therapeutics CEO stellt Strategien für neue FDA-Ära bei Tribe Public Webinar vor

Serina Therapeutics files to sell 7.72M shares of common stock for holders

Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Sale of Common Shares

This Is Why Serina Therapeutics Stock (SER) Rocketed Today

What Sparked Serina Therapeutics (SER) 35% After-Hours Surge?

Benzinga_recent_news

Serina Therapeutics announces FDA clearance of SER-252 new drug application

FDA Clears IND Application for Serina Therapeutics' SER-252 in Advanced Parkinson's Disease

Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Disposal of Common Shares

Serina Therapeutics Faces NYSE Delisting Risk Over Shareholders' Equity Deficiency

Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Disposal of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SER/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SER","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER\",,,,,undefined,":{"symbol":"SER","market":"US","secType":"STK","nameCN":"Serina Therapeutics, Inc.","latestPrice":2.48,"timestamp":1773950400000,"preClose":1.28,"halted":0,"volume":157695022,"hourTrading":{"tag":"盘后","latestPrice":2.5,"preClose":2.48,"latestTime":"19:59 EDT","volume":4633078,"amount":11591037.3895,"timestamp":1773964799305,"change":0.02,"changeRate":0.008065,"amplitude":0.125},"delay":0,"changeRate":0.9375,"floatShares":5193821,"shares":10785600,"eps":-1.783,"marketStatus":"Closed","change":1.2,"latestTime":"03-19 16:00:00 EDT","open":2.1,"high":2.83,"low":2.02,"amount":356810265.7870266,"amplitude":0.632813,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.783,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773993600000},"marketStatusCode":5,"adr":0,"exchange":"AMEX","adjPreClose":1.28,"preHourTrading":{"tag":"盘前","latestPrice":2.12,"preClose":1.28,"latestTime":"09:29 EDT","volume":15179106,"amount":29136438.168507,"timestamp":1773926999999,"change":0.84,"changeRate":0.65625,"amplitude":0.59375},"postHourTrading":{"tag":"盘后","latestPrice":2.5,"preClose":2.48,"latestTime":"19:59 EDT","volume":4633078,"amount":11591037.3895,"timestamp":1773964799305,"change":0.02,"changeRate":0.008065,"amplitude":0.125},"volumeRatio":108.289736},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER\",,,,,undefined,":{"symbol":"SER","floatShares":5193821,"roa":"-137.85%","roe":"-485.36%","lyrEps":-1.513928,"volumeRatio":108.289736,"shares":10785600,"dividePrice":0,"high":2.83,"amplitude":0.632813,"preClose":1.28,"low":2.02,"week52Low":1.22,"pbRate":"-8.41","psRate":"230.59","week52High":7.92,"institutionHeld":0,"latestPrice":2.48,"eps":-1.783,"divideRate":0,"volume":157695022,"delay":0,"ttmEps":-1.783,"open":2.1,"prevYearClose":1.913,"prevWeekClose":1.55,"prevMonthClose":1.8,"prevQuarterClose":1.913,"fiveDayClose":1.56,"twentyDayClose":1.73,"sixtyDayClose":2.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SER\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"SER","fiscalQuarterEnding":"2025/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-08-11","symbol":"SER","fiscalQuarterEnding":"2025/06","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-03-24","symbol":"SER","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-11-12","symbol":"SER","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2024-08-09","symbol":"SER","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SER\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SER\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1752552000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SER\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SER","date":"2026-03-18","current":-1.390914,"percent":0.915612,"low":-65.600015,"twenty":-11.19566,"median":-5.878654,"eighty":-1.647798,"high":37.356482,"avg":-11.184504,"sd":20.751864,"marketCap":14452655},"quantilePoints":[{"date":"2024-04-05","current":29.141387,"twenty":30.584579,"median":32.083279,"eighty":33.732959,"marketCap":105541506},{"date":"2024-04-12","current":17.770243,"twenty":17.783016,"median":23.543628,"eighty":32.232039,"marketCap":93646584},{"date":"2024-04-19","current":17.456349,"twenty":17.731924,"median":17.945869,"eighty":31.172957,"marketCap":91992413},{"date":"2024-04-26","current":14.673941,"twenty":16.787882,"median":17.778226,"eighty":29.502185,"marketCap":77329529},{"date":"2024-05-03","current":14.209648,"twenty":14.673941,"median":17.57865,"eighty":21.283439,"marketCap":74882770},{"date":"2024-05-10","current":14.050147,"twenty":14.209648,"median":17.078432,"eighty":18.800885,"marketCap":74042223},{"date":"2024-05-17","current":12.820759,"twenty":14.187327,"median":15.966076,"eighty":18.090969,"marketCap":67563528},{"date":"2024-05-24","current":15.167772,"twenty":14.187327,"median":15.718602,"eighty":17.818141,"marketCap":79931945},{"date":"2024-05-31","current":-13.721878,"twenty":13.545619,"median":15.079879,"eighty":17.786209,"marketCap":79931945},{"date":"2024-06-07","current":-14.08298,"twenty":12.926135,"median":14.744671,"eighty":17.776629,"marketCap":82035417},{"date":"2024-06-14","current":-14.564515,"twenty":-13.557216,"median":14.673941,"eighty":17.770243,"marketCap":84840426},{"date":"2024-06-21","current":-15.922863,"twenty":-13.825876,"median":14.209648,"eighty":17.731924,"marketCap":92753004},{"date":"2024-06-28","current":-12.919404,"twenty":-13.944317,"median":14.209648,"eighty":17.655287,"marketCap":75257414},{"date":"2024-07-05","current":-11.364849,"twenty":-13.990538,"median":14.209648,"eighty":17.52973,"marketCap":66201907},{"date":"2024-07-12","current":-11.153551,"twenty":-13.799876,"median":13.810656,"eighty":17.339222,"marketCap":64971062},{"date":"2024-07-15","current":-13.477836,"twenty":-13.773877,"median":13.571165,"eighty":17.280659,"marketCap":78510363},{"date":"2024-08-02","current":-12.964682,"twenty":-13.747877,"median":13.539233,"eighty":17.222095,"marketCap":75521166},{"date":"2024-08-09","current":-11.364095,"twenty":-13.723872,"median":13.251843,"eighty":17.027373,"marketCap":66197511},{"date":"2024-08-16","current":-8.441425,"twenty":-13.721878,"median":2.384851,"eighty":16.171527,"marketCap":59150297},{"date":"2024-08-23","current":-10.330099,"twenty":-13.617881,"median":-8.582039,"eighty":15.966076,"marketCap":72384510},{"date":"2024-08-30","current":-10.13985,"twenty":-13.52255,"median":-9.00413,"eighty":15.966076,"marketCap":71051408},{"date":"2024-09-06","current":-10.104487,"twenty":-13.488788,"median":-9.975078,"eighty":15.85112,"marketCap":70803616},{"date":"2024-09-13","current":-7.831133,"twenty":-13.268937,"median":-9.379361,"eighty":15.707426,"marketCap":54873890},{"date":"2024-09-20","current":-7.554188,"twenty":-13.112179,"median":-8.839249,"eighty":15.365752,"marketCap":52933298},{"date":"2024-09-27","current":-9.43006,"twenty":-13.019016,"median":-9.049816,"eighty":15.0623,"marketCap":66077809},{"date":"2024-10-04","current":-8.251303,"twenty":-12.937515,"median":-8.845695,"eighty":14.905865,"marketCap":57818083},{"date":"2024-10-11","current":-8.580848,"twenty":-12.554189,"median":-8.732946,"eighty":14.786183,"marketCap":60127254},{"date":"2024-10-18","current":-9.769745,"twenty":-12.214089,"median":-8.764633,"eighty":14.702233,"marketCap":68458031},{"date":"2024-10-25","current":-8.872369,"twenty":-11.941393,"median":-8.872369,"eighty":14.673941,"marketCap":62169982},{"date":"2024-10-31","current":-8.568173,"twenty":-11.747964,"median":-8.847019,"eighty":14.628789,"marketCap":60038439},{"date":"2024-11-08","current":-5.742165,"twenty":-11.5456,"median":-8.764633,"eighty":14.420496,"marketCap":40236191},{"date":"2024-11-15","current":-6.048407,"twenty":-11.364849,"median":-8.720054,"eighty":14.209648,"marketCap":44459880},{"date":"2024-11-22","current":-5.928673,"twenty":-11.364547,"median":-8.695365,"eighty":14.209648,"marketCap":43570682},{"date":"2024-11-29","current":-6.352149,"twenty":-11.321986,"median":-8.600455,"eighty":14.209648,"marketCap":46682874},{"date":"2024-12-06","current":-7.456945,"twenty":-11.110513,"median":-8.568173,"eighty":14.187327,"marketCap":54802179},{"date":"2024-12-13","current":-6.006451,"twenty":-10.914992,"median":-8.561836,"eighty":14.088465,"marketCap":44142287},{"date":"2024-12-20","current":-7.07266,"twenty":-10.789111,"median":-8.479449,"eighty":13.954351,"marketCap":51978012},{"date":"2024-12-27","current":-6.747673,"twenty":-10.659517,"median":-8.390726,"eighty":13.571165,"marketCap":49589633},{"date":"2025-01-03","current":-6.517639,"twenty":-10.562175,"median":-8.162579,"eighty":13.520073,"marketCap":47899077},{"date":"2025-01-10","current":-5.904214,"twenty":-10.499761,"median":-8.051056,"eighty":13.363605,"marketCap":43390929},{"date":"2025-01-17","current":-6.07035,"twenty":-10.463782,"median":-7.83254,"eighty":13.258229,"marketCap":44611886},{"date":"2025-01-24","current":-6.006451,"twenty":-10.451708,"median":-7.712623,"eighty":13.14966,"marketCap":44142287},{"date":"2025-01-31","current":-5.878654,"twenty":-10.421318,"median":-7.617562,"eighty":12.926135,"marketCap":43203089},{"date":"2025-02-07","current":-5.878654,"twenty":-10.364245,"median":-7.402632,"eighty":5.571028,"marketCap":43203089},{"date":"2025-02-14","current":-5.955332,"twenty":-10.299629,"median":-7.207741,"eighty":-5.38422,"marketCap":43766608},{"date":"2025-02-21","current":-6.249265,"twenty":-10.231108,"median":-7.041606,"eighty":-5.510713,"marketCap":45926762},{"date":"2025-02-28","current":-6.380056,"twenty":-10.13985,"median":-6.713492,"eighty":-5.574659,"marketCap":46887966},{"date":"2025-03-07","current":-6.326216,"twenty":-10.13478,"median":-6.696682,"eighty":-5.743169,"marketCap":46492287},{"date":"2025-03-14","current":-5.532074,"twenty":-10.112497,"median":-6.684888,"eighty":-5.743169,"marketCap":40656021},{"date":"2025-03-21","current":-6.110856,"twenty":-10.104487,"median":-6.616553,"eighty":-5.743169,"marketCap":44909571},{"date":"2025-03-28","current":-4.234631,"twenty":-10.098885,"median":-6.511249,"eighty":-5.532216,"marketCap":47178021},{"date":"2025-04-04","current":-4.894342,"twenty":-10.073941,"median":-6.460817,"eighty":-4.926436,"marketCap":54527860},{"date":"2025-04-11","current":-4.279206,"twenty":-10.051126,"median":-6.404799,"eighty":-4.716041,"marketCap":47674632},{"date":"2025-04-17","current":-4.680381,"twenty":-10.000427,"median":-6.391338,"eighty":-4.680381,"marketCap":52144128},{"date":"2025-04-25","current":-5.429242,"twenty":-9.949728,"median":-6.352149,"eighty":-4.680381,"marketCap":60487189},{"date":"2025-05-02","current":-4.733871,"twenty":-9.769745,"median":-6.319486,"eighty":-4.680381,"marketCap":52740061},{"date":"2025-05-09","current":-5.121942,"twenty":-9.696231,"median":-6.287604,"eighty":-4.698211,"marketCap":57063554},{"date":"2025-05-16","current":-59.867974,"twenty":-10.063801,"median":-6.319486,"eighty":-4.716041,"marketCap":56216028},{"date":"2025-05-23","current":-62.521698,"twenty":-10.1145,"median":-6.352149,"eighty":-4.716041,"marketCap":58707874},{"date":"2025-05-30","current":-61.035612,"twenty":-10.269158,"median":-6.380056,"eighty":-4.730305,"marketCap":57312440},{"date":"2025-06-06","current":-63.15859,"twenty":-10.460251,"median":-6.404799,"eighty":-4.739577,"marketCap":59305916},{"date":"2025-06-13","current":-62.893218,"twenty":-10.844881,"median":-6.460817,"eighty":-4.756693,"marketCap":59056732},{"date":"2025-06-20","current":-61.035612,"twenty":-11.364397,"median":-6.504859,"eighty":-4.787361,"marketCap":57312440},{"date":"2025-06-27","current":-65.069271,"twenty":-11.941393,"median":-6.601297,"eighty":-4.858682,"marketCap":61100045},{"date":"2025-07-03","current":-63.052442,"twenty":-12.946571,"median":-6.683774,"eighty":-4.897908,"marketCap":59206243},{"date":"2025-07-11","current":-62.585387,"twenty":-13.494265,"median":-6.687561,"eighty":-4.963879,"marketCap":58767678},{"date":"2025-07-18","current":-56.365062,"twenty":-13.727859,"median":-6.706215,"eighty":-5.054812,"marketCap":52926793},{"date":"2025-07-25","current":-57.320401,"twenty":-14.163867,"median":-6.747673,"eighty":-5.06551,"marketCap":53823857},{"date":"2025-08-01","current":-58.806486,"twenty":-14.540367,"median":-7.140201,"eighty":-5.097711,"marketCap":55219290},{"date":"2025-08-08","current":-57.851146,"twenty":-16.339423,"median":-7.348318,"eighty":-5.123618,"marketCap":54322226},{"date":"2025-08-15","current":-4.477661,"twenty":-17.151414,"median":-7.290809,"eighty":-5.06551,"marketCap":56378234},{"date":"2025-08-22","current":-4.477661,"twenty":-16.339423,"median":-7.07266,"eighty":-4.840851,"marketCap":56378234},{"date":"2025-08-29","current":-4.176437,"twenty":-15.621008,"median":-6.732661,"eighty":-4.723173,"marketCap":52585516},{"date":"2025-09-05","current":-4.298555,"twenty":-15.168225,"median":-6.706215,"eighty":-4.683947,"marketCap":54123104},{"date":"2025-09-12","current":-4.152013,"twenty":-15.047483,"median":-6.687561,"eighty":-4.603418,"marketCap":52277998},{"date":"2025-09-19","current":-3.671682,"twenty":-14.552441,"median":-6.683774,"eighty":-4.480762,"marketCap":46230151},{"date":"2025-09-26","current":-4.054319,"twenty":-14.495088,"median":-6.586042,"eighty":-4.445795,"marketCap":51047928},{"date":"2025-10-03","current":-4.274131,"twenty":-14.455909,"median":-6.482838,"eighty":-4.363684,"marketCap":53815587},{"date":"2025-10-10","current":-4.670023,"twenty":-14.397862,"median":-6.433897,"eighty":-4.347636,"marketCap":58800259},{"date":"2025-10-17","current":-4.092547,"twenty":-14.188422,"median":-6.402621,"eighty":-4.323139,"marketCap":51529260},{"date":"2025-10-24","current":-4.322701,"twenty":-14.088758,"median":-6.364249,"eighty":-4.310147,"marketCap":54427122},{"date":"2025-10-31","current":-4.008855,"twenty":-14.036759,"median":-6.339182,"eighty":-4.297619,"marketCap":50475491},{"date":"2025-11-07","current":-3.448117,"twenty":-13.827869,"median":-6.299296,"eighty":-4.264361,"marketCap":43415245},{"date":"2025-11-14","current":-3.280733,"twenty":-13.729853,"median":-6.273601,"eighty":-4.236343,"marketCap":41307709},{"date":"2025-11-21","current":-2.15737,"twenty":-13.721878,"median":-6.249265,"eighty":-4.197811,"marketCap":40096880},{"date":"2025-11-28","current":-2.444254,"twenty":-13.721878,"median":-6.245456,"eighty":-4.152013,"marketCap":45428912},{"date":"2025-12-05","current":-1.990977,"twenty":-13.591882,"median":-6.147028,"eighty":-4.102049,"marketCap":37004302},{"date":"2025-12-12","current":-1.801633,"twenty":-13.505217,"median":-6.121468,"eighty":-4.090954,"marketCap":33485160},{"date":"2025-12-19","current":-1.524503,"twenty":-13.477836,"median":-6.11051,"eighty":-4.06246,"marketCap":28334418},{"date":"2025-12-26","current":-1.399995,"twenty":-13.199304,"median":-6.089519,"eighty":-4.041726,"marketCap":26020316},{"date":"2026-01-02","current":-1.097619,"twenty":-13.112179,"median":-6.083129,"eighty":-3.997732,"marketCap":20400354},{"date":"2026-01-09","current":-1.503274,"twenty":-13.019016,"median":-6.07035,"eighty":-3.774262,"marketCap":27939847},{"date":"2026-01-16","current":-1.543438,"twenty":-12.937515,"median":-6.048407,"eighty":-3.438074,"marketCap":28686332},{"date":"2026-01-23","current":-1.698355,"twenty":-12.675928,"median":-6.046598,"eighty":-3.349361,"marketCap":31565629},{"date":"2026-01-30","current":-2.031141,"twenty":-12.246297,"median":-6.019231,"eighty":-2.444254,"marketCap":37750786},{"date":"2026-02-06","current":-1.433355,"twenty":-12.01082,"median":-6.006451,"eighty":-2.225304,"marketCap":26640343},{"date":"2026-02-13","current":-0.98652,"twenty":-11.747964,"median":-6.006451,"eighty":-2.15737,"marketCap":18335458},{"date":"2026-02-20","current":-1.003929,"twenty":-11.605851,"median":-5.962795,"eighty":-2.0036,"marketCap":18659025},{"date":"2026-02-27","current":-1.050353,"twenty":-11.364849,"median":-5.922833,"eighty":-1.871633,"marketCap":19521870},{"date":"2026-03-06","current":-0.91108,"twenty":-11.364698,"median":-5.904214,"eighty":-1.792453,"marketCap":16933335},{"date":"2026-03-13","current":-0.905277,"twenty":-11.321986,"median":-5.880344,"eighty":-1.689175,"marketCap":16825479},{"date":"2026-03-18","current":-0.77761,"twenty":-11.19566,"median":-5.878654,"eighty":-1.647798,"marketCap":14452655}],"updateTime":1773960920031},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SER\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620706220","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2620706220","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620706220?lang=en_us&edition=fundamental","pubTime":"2026-03-20 01:31","pubTimestamp":1773941506,"startTime":"0","endTime":"0","summary":"Serina Therapeutics  shares rose in midday trading on Thursday after the company said late Wednesday it has entered agreements to offer common shares and pre-funded warrants at $2.25 apiece for gross proceeds of $15 million.Shares jumped roughly 115% in midday trading as volume climbed to more than 125.9 million from a daily average of about 1.5 million.Envela  shares were up nearly 44% after the company reported higher Q4 results late Wednesday.Intraday trading volume rose to over 1.3 million shares from a daily average of about 81,000.Duluth Holdings  stock was up about 43% after the company swung to adjusted earnings of $0.23 per share in fiscal Q4 from a loss of $0.10 per share in the same quarter a year ago.Intraday trading volume stood at nearly 10.9 million shares versus a daily average of roughly 63,000.Price: 2.73, Change: +1.45, Percent Change: +112.89","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SER.AU","DLTH","BK4094","BK4200","BK4139","ELA","BK4122","SER","BK7095"],"gpt_icon":0},{"id":"2620222174","title":"Gold Tumbles Over 6%; Accenture Earnings Top Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2620222174","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620222174?lang=en_us&edition=fundamental","pubTime":"2026-03-20 00:01","pubTimestamp":1773936107,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/03/51360101/gold-tumbles-over-6-accenture-earnings-top-views","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","LU0265550946.USD","LU0553294199.USD","LU0545039389.USD","LU0149725797.USD","LU0342679015.USD","SUNE","LU1235294995.USD","IE00BJJMRY28.SGD","LU0175139822.USD","IE00BFSS7M15.SGD","SG9999014898.SGD","UCAR","LU2211815571.USD","LU1366333091.USD","BK4079","SG9999014914.USD","UOKA","LU0868494708.USD","SG9999014880.SGD","LU1823568750.SGD","LU0868494617.USD","ACN","LU1116320901.HKD","BK4585","LU0323240290.USD","LU1506573853.SGD","RVPH","BK4134","LU0545562505.USD","ELA","LU1228905037.USD","BK4561","SG9999004303.SGD","IE00BSNM7G36.USD","LU1228905540.USD","SG9999018857.SGD","SG9999018865.SGD","SGXZ23171101.USD","BK4200","LU0265550359.USD","SER","LU1430594728.SGD","BK4007","BK4534","IE000M9KFDE8.USD","SG9999014906.USD","LU0661504455.SGD","IE00BFSS8Q28.SGD","LU0289960550.SGD"],"gpt_icon":0},{"id":"2620426761","title":"Serina Therapeutics names Greg Bailey co-chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2620426761","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620426761?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:30","pubTimestamp":1773865841,"startTime":"0","endTime":"0","summary":"Serina Therapeutics (SER) announced Greg Bailey, a current board director, will assume the role of co-chairman of the board of directors. Greg Bail...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-names-greg-bailey-co-chairman-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-names-greg-bailey-co-chairman-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539","SER"],"gpt_icon":0},{"id":"2620526282","title":"Serina Therapeutics announces USD 15 million private placement of common stock and pre-funded warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2620526282","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620526282?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:11","pubTimestamp":1773864683,"startTime":"0","endTime":"0","summary":"Serina announced definitive agreements for a private placement of common stock and pre-funded warrants expected to raise USD 15 million in gross proceeds. The first tranche is expected to close on March 20, 2026, and a second tranche of up to USD 15 million is expected to close on or before April 30, 2026. The securities are priced at USD 2.25 per share and include 50% warrant coverage with an exercise price of USD 5 per share. Serina said the warrants related to the first tranche, if fully exercised, would provide additional gross cash proceeds of USD 16.7 million. The securities are being offered in an unregistered private placement under Section 4 of the Securities Act and/or Regulation D.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL7b6hN3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","BK4112","BK4588","IE00BGHQF748.EUR","LU0314104364.USD","SG9999014021.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00B3QW5Z07.USD","SER","LU2095319765.USD","IE00B64PRP62.GBP","NDAQ","SG9999014039.USD","IE00BKPKM429.USD","SG9999014013.SGD","LU2210150020.SGD","LU2210149790.SGD","BK4139","BK4585","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2616015322","title":"Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2616015322","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616015322?lang=en_us&edition=fundamental","pubTime":"2026-03-04 00:33","pubTimestamp":1772555587,"startTime":"0","endTime":"0","summary":"Serina Therapeutics, Inc. ($SER) announced an update on their ongoing clinical study. The study, titled “A Randomized, Placebo-Controlled, Single A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/serina-therapeutics-advances-ser-252-parkinsons-trial-marking-a-key-early-milestone-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/serina-therapeutics-advances-ser-252-parkinsons-trial-marking-a-key-early-milestone-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4211","SER","ISBC","SERDB"],"gpt_icon":0},{"id":"2614725620","title":"Serina Therapeutics: Blinded Evaluation of Safety, Tolerability Data From Cohort 1 & Advancement to Cohort 2 Expected in 3Q 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2614725620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614725620?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:50","pubTimestamp":1771969834,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK1F1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SER"],"gpt_icon":0},{"id":"2614725834","title":"Serina Therapeutics doses first patient in SER-252 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2614725834","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614725834?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:37","pubTimestamp":1771969055,"startTime":"0","endTime":"0","summary":"Serina Therapeutics (SER) announced that it has dosed the first patient in its Phase 1b registrational clinical trial evaluating SER-252 in patient...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-doses-first-patient-in-ser-252-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-doses-first-patient-in-ser-252-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SER","BK4139"],"gpt_icon":0},{"id":"2614728490","title":"Serina Therapeutics doses first patient in Phase 1b registrational trial of SER-252 for advanced Parkinson’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2614728490","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614728490?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:14","pubTimestamp":1771967698,"startTime":"0","endTime":"0","summary":"Serina Therapeutics said it dosed the first patient in its Phase 1b registrational clinical trial of SER-252 for advanced Parkinson’s disease. The study is designed to evaluate safety, tolerability, pharmacokinetics and preliminary efficacy in patients whose symptoms are inadequately controlled by standard-of-care therapies. The company expects a blinded Safety Monitoring Committee review of Cohort 1 safety and tolerability data and a potential advancement to Cohort 2 in the third quarter of 2026. Serina also reported FDA alignment on a 505 NDA pathway and said initial dosing is underway at global clinical sites, including Australia.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL3FvCr2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"gpt_icon":0},{"id":"2612409976","title":"Serina Therapeutics enrolls first patient in Phase 1b registrational trial of SER-252 for advanced Parkinson’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2612409976","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612409976?lang=en_us&edition=fundamental","pubTime":"2026-02-19 19:00","pubTimestamp":1771498824,"startTime":"0","endTime":"0","summary":"Serina Therapeutics said it has enrolled the first patient in a global Phase 1b registrational trial of SER-252 for advanced Parkinson’s disease. The study will evaluate safety, tolerability, pharmacokinetics and preliminary efficacy in patients whose symptoms are inadequately controlled by standard therapies, with first dosing expected in the first quarter of 2026. No trial results have been presented yet; the company said it will provide updates as enrollment progresses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL4044S9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","SG9999014021.USD","BK4139","IE00BKPKM429.USD","BK4112","LU0314104364.USD","SG9999014013.SGD","SG9999014005.SGD","LU2210150020.SGD","LU2095319765.USD","SER","SG9999014039.USD"],"gpt_icon":0},{"id":"2608980953","title":"Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2608980953","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608980953?lang=en_us&edition=fundamental","pubTime":"2026-02-04 01:36","pubTimestamp":1770140173,"startTime":"0","endTime":"0","summary":"Randall Moreadith, Chief Scientific Officer of Serina Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL9PtSlt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"gpt_icon":0},{"id":"2608827162","title":"Serina Therapeutics CEO stellt Strategien für neue FDA-Ära bei Tribe Public Webinar vor","url":"https://stock-news.laohu8.com/highlight/detail?id=2608827162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608827162?lang=en_us&edition=fundamental","pubTime":"2026-02-03 19:00","pubTimestamp":1770116422,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL7fdbNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","SER","BK4588","BK4139","IE00BGHQF748.EUR","SG9999014021.USD","NDAQ","SG9999014039.USD","LU2210150020.SGD","LU0314104364.USD","BK4112","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210149790.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2607283022","title":"Serina Therapeutics files to sell 7.72M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2607283022","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607283022?lang=en_us&edition=fundamental","pubTime":"2026-01-31 06:25","pubTimestamp":1769811913,"startTime":"0","endTime":"0","summary":"17:20 EST Serina Therapeutics (SER) files to sell 7.72M shares of common stock for holders Published first on TheFly – the ultimate source for real...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-files-to-sell-7-72m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-files-to-sell-7-72m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","LENZ","SER","BK4139"],"gpt_icon":0},{"id":"2607372770","title":"Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2607372770","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607372770?lang=en_us&edition=fundamental","pubTime":"2026-01-30 01:54","pubTimestamp":1769709272,"startTime":"0","endTime":"0","summary":"Randall Moreadith, Chief Scientific Officer of Serina Therapeutics Inc., has reported a disposal of common shares of the company, according to a recent regulatory filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL4RRN7m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"gpt_icon":0},{"id":"2607036423","title":"This Is Why Serina Therapeutics Stock (SER) Rocketed Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2607036423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607036423?lang=en_us&edition=fundamental","pubTime":"2026-01-29 22:53","pubTimestamp":1769698383,"startTime":"0","endTime":"0","summary":"Serina Therapeutics stock was on the rise after the company received good news from the FDA.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/this-is-why-serina-therapeutics-stock-ser-rocketed-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/this-is-why-serina-therapeutics-stock-ser-rocketed-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SER","BK4139"],"gpt_icon":0},{"id":"2607000774","title":"What Sparked Serina Therapeutics (SER) 35% After-Hours Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2607000774","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607000774?lang=en_us&edition=fundamental","pubTime":"2026-01-29 13:09","pubTimestamp":1769663340,"startTime":"0","endTime":"0","summary":"Serina Therapeutics shares jumped nearly 35% after the FDA cleared its IND application for SER-252, advancing plans for a Phase 1b trial in advanced Parkinson's disease.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/29/Stock-Market-Trading-Graph.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/29/Stock-Market-Trading-Graph.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/01/50215493/what-sparked-serina-therapeutics-ser-35-after-hours-surge","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/01/50215493/what-sparked-serina-therapeutics-ser-35-after-hours-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","BK4150","SER","RSI"],"gpt_icon":0},{"id":"2607723460","title":"Serina Therapeutics announces FDA clearance of SER-252 new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2607723460","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607723460?lang=en_us&edition=fundamental","pubTime":"2026-01-29 05:31","pubTimestamp":1769635890,"startTime":"0","endTime":"0","summary":"Serina Therapeutics (SER) announced that the FDA has cleared its investigational new drug application for SER-252, an investigational therapy for a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-announces-fda-clearance-of-ser-252-new-drug-application-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-announces-fda-clearance-of-ser-252-new-drug-application-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SER"],"gpt_icon":0},{"id":"2607740330","title":"FDA Clears IND Application for Serina Therapeutics' SER-252 in Advanced Parkinson's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2607740330","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607740330?lang=en_us&edition=fundamental","pubTime":"2026-01-29 05:03","pubTimestamp":1769634226,"startTime":"0","endTime":"0","summary":"Serina Therapeutics Inc. announced that the U.S. Food and Drug Administration  has cleared its Investigational New Drug  application for SER-252, an investigational therapy for advanced Parkinson's disease. The clearance allows the company to proceed with regulatory and site-level activities to support the initiation of a planned Phase 1b registrational clinical study. The FDA has provided feedback supporting the proposed clinical trial design under a 505 New Drug Application  pathway. Phase 1b clinical site start-up and regulatory activities in Australia are also underway as part of the global registrational program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL3NvKVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"gpt_icon":0},{"id":"2605443443","title":"Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605443443","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605443443?lang=en_us&edition=fundamental","pubTime":"2026-01-22 08:17","pubTimestamp":1769041066,"startTime":"0","endTime":"0","summary":"Randall Moreadith, Chief Scientific Officer of Serina Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL5MVZtn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"gpt_icon":0},{"id":"2603935660","title":"Serina Therapeutics Faces NYSE Delisting Risk Over Shareholders' Equity Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2603935660","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603935660?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:03","pubTimestamp":1768511039,"startTime":"0","endTime":"0","summary":"Serina Therapeutics Inc. has received a deficiency notification from the New York Stock Exchange  regarding its stockholders' equity, which fell to $1.6 million as of September 30, 2025. The company has also reported losses in three of its four most recent fiscal years, putting it below the continued listing criteria under Sections 1003 and  of the NYSE American Company Guide. Serina must submit a compliance plan by February 8, 2026, outlining actions to regain compliance by July 9, 2027. Failure to submit an acceptable plan may result in delisting proceedings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL5wXrSD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"gpt_icon":0},{"id":"2603838646","title":"Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603838646","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603838646?lang=en_us&edition=fundamental","pubTime":"2026-01-15 01:57","pubTimestamp":1768413442,"startTime":"0","endTime":"0","summary":"Randall Moreadith, Chief Scientific Officer of Serina Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 14, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL4Mzbr5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":51,"code":"91000000","status":"200"}]}}